Modernawould give the European Commission the option to double its quantity of COVID-19 vaccines, bringing the total amount of available doses to 160 million.
The US-based biotechnology company, confirmed on Monday advanced talks were conducted with the European Commission to supply another 80 million doses of Moderna’s potential vaccine against COVID-19, called mRNA-1273, as part of the European Commission’s goal to secure early access to safe and effective COVID-19 vaccines for Europe.
Full Story (Jerusalem Post)
